GPCR Therapeutics launches multiple myeloma trial
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
January 19, 2023 - 2 minutes
GPCR
Sosei Heptares signs R&D agreements on gastrointestinal and immune disorders
Sosei Heptares has entered translational medicine and R&D agreements with the MRC Weatherall Institute of…
December 8, 2022 - 3 minutes
PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way
PrecisionLife, developers of precision medicine for chronic diseases, will be supporting biopharmaceutical group, Sosei Heptares,…
November 9, 2022 - 3 minutes
OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
April 28, 2022 - 3 minutes
Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
May 7, 2019 - 3 minutes
British Biotech Founder Receives the Nobel Prize in Chemistry 2017
Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology…
October 5, 2017 - 2 minutes
Meet the Young CEO of a PCR Workflow Automation Company
He is a young entrepreneur with a fast growing company. His software for the automation…
October 2, 2017 - 7 minutes
Belgian Biotech Teams Up With Lundbeck to Collaborate on Drug Discovery
Confo and Lundbeck have joined forces to push through drug discovery against a tough-to-target protein…
September 26, 2017 - 2 minutes
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat…
September 1, 2017 - 2 minutes
Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares
Heptares is expanding into a range of indications with its GPCR platform. I caught up…
July 17, 2017 - 6 minutes
MorphoSys’ First Lanthipeptide Completes Phase I Successfully
UPDATE (19/05/2017): MorphoSys has announced the completion of the Phase I study with MOR107, which…
May 19, 2017 - 2 minutes
Heptares receives €4.5M Milestone for New Migraine Drug Candidate
The UK biotech attacking notoriously evasive GPCRs has discovered a small molecule that could be…
May 18, 2017 - 1 minute
